Get notified of changes to Red Book Online: Sign up for e-alerts
The Red Book is published every three years, but advancements in medicine happen continuously. The Red Book Online platform provides the mechanism to update chapters between publication years when new recommendations are published by the American Academy of Pediatrics as Policy Statements, or by other national or international organizations such as the Centers for Disease Control and Prevention, the National Institutes of Health, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, or the World Health Organization.
The following changes from the print edition have been updated on Red Book Online.
Type of Change |
Details |
Chapter updates |
On February 14, 2025, updates were made to the following chapter:
On November 11, 2024, updates were made to the following chapters:
|
Errata |
July 24, 2024:
- Page 813: In Table 3.68 in the “Streptococcus pneumoniae (Pneumococcal) Infections” chapter, the breakpoint for CEFOTAXIME OR CEFTRIAXONE in the Meningitis listing under the first column, “Susceptible” has been corrected from <0.5 to ≤0.5. The table has been updated on Red Book Online and a revised page 813 appears on page 2 of this Errata. View the Errata.
|
Minor updates |
- Page xxxvii, Summary of Major Changes in the 2024 Red Book, entry #2: “The listing below outlines the more major changes throughout the 2014” corrected to The listing below outlines the more major changes throughout the 2024 edition.”
- Page 71, Active Immunization: “graded increase in vaccine dose that is administration” corrected to “graded increase in vaccine dose administered”
- Page 330, Coronavirus Disease 2019 (COVID-19): “People eligible for additional doses include are those” corrected to “People eligible for additional doses include those”
- Page 450, Hepatitis B chapter, Figure 3.5: footnote "a" reference added in the text box (third box down at far left of figure) to read: “Hepatitis B vaccinea and HBIG within 12 hours of birth”
- Page 461, Hepatitis C chapter, Figure 3.6: footnote updated from “Modified Conners EE, Panagiotakopoulos L, Hofmeister MG, et al. Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023. MMWR Recomm Rep. 2023;72(RR-1):1-25.” to “Modified from Panagiotakopoulos L, Sandul AL, Conners EE, Foster MA, Nelson NP, Wester C. CDC recommendations for hepatitis C testing among perinatally exposed infants and children—United States, 2023. MMWR Recomm Rep. 2023;72(RR-4):1-19.”
- Page 485, Human Herpesvirus 6 (Including Roseola) and 7, “RandBP2” corrected to “RANBP2”.
- Page 595, Meningococcal B Vaccines, Table 3.40, in section Meningococcal B Vaccines: “Other than outbreak: boosterg” corrected to “Other than outbreak: boosterh”
- Page 637, Parechovirus chapter: “(especially younger than 6 months of age infected with HPeV-6)” corrected to “(especially younger than 6 months of age infected with HPeV-3)”
- Page 851, Tetanus chapter, Figure 3.19: “Administer vaccine and tetanus immune gobulin (TIG) now.” corrected to “Administer vaccine and tetanus immune globulin (TIG) now.”
- Page 851, Tetanus chapter, Figure 3.19, footnote 1: “doses of tetanus- and diphtheriacontaining.” corrected to “doses of tetanus- and diphtheria-containing.”
|
Please visit the Previous Editions page for notices of updates and errata from previous editions. If you need further assistance, please contact us.